BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11899081)

  • 1. Gene therapy for diabetes mellitus.
    Yamaoka T
    Curr Mol Med; 2001 Jul; 1(3):325-37. PubMed ID: 11899081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gene therapy for diabetes mellitus].
    Yamaoka T; Itakura M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():650-7. PubMed ID: 12387065
    [No Abstract]   [Full Text] [Related]  

  • 3. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
    Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
    Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy in diabetes mellitus: promises and piffalls.
    Welsh N
    Curr Opin Mol Ther; 1999 Aug; 1(4):464-70. PubMed ID: 11713761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets.
    Téllez N; Montolio M; Biarnés M; Castaño E; Soler J; Montanya E
    Gene Ther; 2005 Jan; 12(2):120-8. PubMed ID: 15578044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches for the cure of type 1 diabetes by cellular and gene therapy.
    Jun HS; Yoon JW
    Curr Gene Ther; 2005 Apr; 5(2):249-62. PubMed ID: 15853732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regeneration therapy of pancreatic beta cells: towards a cure for diabetes?
    Yamaoka T
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1039-43. PubMed ID: 12207876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering pancreatic islets.
    Soria B; Andreu E; Berná G; Fuentes E; Gil A; León-Quinto T; Martín F; Montanya E; Nadal A; Reig JA; Ripoll C; Roche E; Sanchez-Andrés JV; Segura J
    Pflugers Arch; 2000 May; 440(1):1-18. PubMed ID: 10863992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus-cell transplantation and gene therapy approaches.
    Halvorsen T; Levine F
    Curr Mol Med; 2001 May; 1(2):273-86. PubMed ID: 11899076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically engineered pancreatic beta-cell lines for cell therapy of diabetes.
    Efrat S
    Ann N Y Acad Sci; 1999 Jun; 875():286-93. PubMed ID: 10415575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated islets in diabetes research.
    Bhonde R; Shukla RC; Kanitkar M; Shukla R; Banerjee M; Datar S
    Indian J Med Res; 2007 Mar; 125(3):425-40. PubMed ID: 17496366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene and cell therapies for diabetes mellitus: strategies and clinical potential.
    Giannoukakis N; Robbins PD
    BioDrugs; 2002; 16(3):149-73. PubMed ID: 12102644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for gene therapy of insulin-dependent diabetes mellitus.
    Efrat S
    Diabetologia; 1998 Dec; 41(12):1401-9. PubMed ID: 9867206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for diabetes mellitus.
    Docherty K
    Clin Sci (Lond); 1997 Apr; 92(4):321-30. PubMed ID: 9176029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-secreting non-islet cells are resistant to autoimmune destruction.
    Lipes MA; Cooper EM; Skelly R; Rhodes CJ; Boschetti E; Weir GC; Davalli AM
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8595-600. PubMed ID: 8710916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-producing cells derived from stem cells: recent progress and future directions.
    Santana A; Enseñat-Waser R; Arribas MI; Reig JA; Roche E
    J Cell Mol Med; 2006; 10(4):866-83. PubMed ID: 17125591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward cell-based therapy of type I diabetes.
    Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
    Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human type 2 diabetes: morphological evidence for abnormal beta-cell function.
    Sempoux C; Guiot Y; Dubois D; Moulin P; Rahier J
    Diabetes; 2001 Feb; 50 Suppl 1():S172-7. PubMed ID: 11272184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.